Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 4320 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 42 43 44  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Bind-X–High-Tech Gründerfonds: investment, 202308 existing investor HTGF 2023-08-01
Bind-X–K&K 1: investment, 202308 financing round Series B totalling €10m incl new investor K&K 1 2023-08-01
Bind-X–Saxovent: investment, 202308 financing round Series B totalling €10m incl new investor Saxovent Smart Eco Investments 2023-08-01
Bind-X–SEVERAL: investment, 202308 financing round Series B €10m with HG Ventures + K&K1 + Greeneering Invest + Saxovent 2023-08-01
Bind-X–Vantage Value: investment, 202308 existing investor Vantage Value 2023-08-01
Cellbox Solutions–EU (govt): grant, 202308–202507 EIC Accelerator grant €2.5m 2023-08-01
Reata–Biogen: investment, 202307– acquisition $7.3b in cash by Biogen at $172.5/share ANNOUNCED 2023-07-28
AaviGen–Hopp Group: investment, 202307 financing round Series B €17m from existing investor DH-LT Investments GmbH 2023-07-26
Crescendo Biologics–BioNTech: investment, 202307 financing round totalling $32m incl existing investor BioNTech 2023-07-24
Crescendo Biologics–SEVERAL: investment, 202307 financing round $32m with new investor Kreos Capital + all major existing investors 2023-07-24
Epigenomics–New Day Diagnostics: investment, 202307– acquisition of substantially all assets up to $12.05m plus license + milestones by New Day SIGNED 2023-07-24
Immatics–BMS: investment, 202307 private placement $35m with 2.42m ordinary shares at $14.461/share 2023-07-24
Roche–Alnylam: zilebesiran, 202307– collab $310m upfront + milestones developm + commerc in US w cost/profit sharing + excl ww outside US by Roche 2023-07-24
LimmaTech Biologics–Trophic Communications: public relations, 202307 service existent by Trophic 2023-07-20
Mage Biologics–SEVERAL: investment, 202307– Mage Biologics launches with up to $28m to be invested by Tillotts Pharma + TVM LSI II 2023-07-20
Mage Biologics–TVM: investment, 202307– Mage Biologics launches with up to $28m to be invested by Tillotts Pharma + TVM LSI II 2023-07-20
Mage Biologics–Zeria: investment, 202307– Mage Biologics launches with up to $28m to be invested by Tillotts Pharma + TVM LSI II 2023-07-20
TVM–MC Services: public relations, 202307 service existent by MC Services 2023-07-20
Pieris–Stifel: financial services, 202307– supply service Pieris retains Stifel Nicolaus as excl financial advisor to evaluate strategic options 2023-07-18
AATec Medical–SEVERAL: investment, 202307 seed financing round €2.7m from private investors + industry experts + family offices 2023-07-17
DTx Pharma–Novartis: investment, 202307 acquisition of DTx Pharma for $500m upfront + $500m milestones 2023-07-17
Tenpoint Therapeutics–SEVERAL: investment, 202307 financing round Series A $70m led by F-Prime Capital + Sofinnova Partners + British Patient Capital 2023-07-12
Vertama–BACB: investment, 202307 seed financing round totalling 7-digit € incl investor Berlin Angel Fund 2023-07-12
Vertama–High-Tech Gründerfonds: investment, 202307 seed financing round totalling 7-digit € incl lead investor HTGF 2023-07-12
Vertama–OTHER: investment, 202307 seed financing round totalling 7-digit € incl renowned business angels 2023-07-12
Vertama–SEVERAL: investment, 202307 seed financing round 7-digit € led by HTGF 2023-07-12
Aphea.Bio–SEVERAL: investment, 202307 financing round Series C €70m led by Innovation Industries 2023-07-11
Celares–Biosynth: investment, 202307 acquisition of Celares by Biosynth 2023-07-11
Mallia Therapeutics–MC Services: public relations, 202307 service existent by MC Services 2023-07-11
Mallia Therapeutics–SEVERAL: investment, 202307c– seed financing round raising ongoing 7/23 2023-07-11
BioNTech–Doer Biologics: biopharmaceuticals, 202308– license ww to use Doer Bio discovery to develop + market biotherapeutics against one target 2023-07-10
TolerogenixX–Akampion: public relations, 202307 service existent by Akampion 2023-07-06
TolerogenixX–Bruchmann Group: investment, 202307 financing round Series A 2nd closing totalling €7m incl new investor DB Speciality 2023-07-06
TolerogenixX–SEVERAL: investment, 202307 financing round Series A 2nd closing €7m bringing total round to €11.6m 2023-07-06
Zoetis–Numaferm: peptide technology, 202307– license + collab €na using peptein technology for RnD of veterinary therapeutics 2023-07-06
Acousia Therapeutics–Golgi Neurosciences: investment, 202307 existent investment at time of spin-off of Golgi Neurosciences from Axxam 2023-07-05
Cellbox Solutions–Akampion: public relations, 202307 service existent by Akampion 2023-07-05
inContAlert–SEVERAL: investment, 202307 pre-seed financing round €1.5m led by HTGF + Bayern Kapital + Carma Fund 2023-07-01
Emergence Therapeutics–Lilly: investment, 202306 acquisition 100% of Emergence Therapeutics AG by Eli Lilly 2023-06-29
Gleamer–Heal Capital: investment, 202306 financing round Series B totalling €27m incl new + co-lead investor Heal Capital 2023-06-28
Gleamer–SEVERAL: investment, 202306 financing round Series B €27m led by Supernova Invest + co-led by Heal Capital 2023-06-28
MoonLake–Consilium: public relations, 202306 service existent by Consilium Strategic Communications 2023-06-28
Astraveus–Merck (DE): investment, 202306 seed financing round totalling €16.5m incl co-investor M Ventures 2023-06-27
Astraveus–SEVERAL: investment, 202306 seed financing round €16.5m led by AdBio Partners 2023-06-27
Docflix–SEVERAL: investment, 202306 seed financing round €2m led by HTGF + Brandenburg Kapital 2023-06-27
EBAMed–EFI Lake Geneva Ventures: investment, 202306 financing round Series A totalling €14.35m incl co-investor Efficient Frontier Investing 2023-06-27
EBAMed–EU (govt): investment, 202306 financing round Series A totalling €14.35m incl co-investor EIC Fund 2023-06-27
EBAMed–LIFIT Venture Capital Italia: investment, 202306 financing round Series A totalling €14.35m incl co-investor LIFIT 2023-06-27
EBAMed–Mayo Clinic: investment, 202306 financing round Series A totalling €14.35m incl existing + co-investor Mayo Clinic 2023-06-27
EBAMed–Occident: investment, 202306 financing round Series A totalling €14.35m incl co-investor Occident 2023-06-27
EBAMed–Panakès Partners: investment, 202306 financing round Series A totalling €14.35m incl lead investor Panakès Partners 2023-06-27
EBAMed–SEVERAL: investment, 202306 financing round Series A €14.35m led by Panakès Partners 2023-06-27
Hema.to–SEVERAL: investment, 202306 seed financing round €3.6m with Elaia Partners + Heal Capital + HTGF 2023-06-26
MoonLake–SEVERAL: investment, 202306 public offering $400m+$60m with 8m+1.2m Class A ordinary shares at $50/share 2023-06-26
Lunaphore–Bio-Techne: investment, 202306– acquisition by of Lunaphore by Bio-Techne ANNOUNCED 2023-06-22
MESI–SHS Capital: investment, 202306 investment €18m by SHS in MESI 2023-06-22
Sanofi–SandboxAQ: AI-based drug discovery, 202306 collab existent disclosed of Sanofi with AQBioSim 2023-06-22
Tagworks Pharmaceuticals–Novartis: investment, 202306 financing round Series A totalling $65m incl co-investor Novartis Venture Fund 2023-06-22
Tagworks Pharmaceuticals–SEVERAL: investment, 202306 financing round Series A $65m led by Ysios Capital + Gilde Healthcare 2023-06-22
Pieris–Kendall Investor Relations: public relations, 202306 supply service existent IR by Kendall IR 2023-06-21
Innovative Health Initiative–EU (govt): grant, 202306– funding €24m for IMAGIO project from IHI 2023-06-20
Innovative Health Initiative–Philips: targeted cancer therapy, 202306– Philips is coordinating partner ot the IMAGIO project of IHI 2023-06-20
Innovative Health Initiative–Thermosome: targeted cancer therapy, 202306– Thermosome is partner in IMAGIO project of IHI 2023-06-20
Thermosome–Innovative Health Initiative: grant, 202306– funding €1.3m as partner in IMAGIO project of IHI 2023-06-20
DNTox–SEVERAL: investment, 202306 seed financing round €1.4m led by HTGF 2023-06-14
Danish National Genome Center–Qiagen: genomic software tools, 202306– supply QCI Interpret software for oncology genome sequencing by Qiagen 2023-06-13
Dynamic42–OTHER: investment, 202306 financing round Series A totalling mid-7-figure € incl a family office from the health sector 2023-06-13
Dynamic42–SEVERAL: investment, 202306 financing round Series A mid-7-figure € incl investors bm-t + a familly office 2023-06-13
Dynamic42–Thuringia (govt): investment, 202306 financing round Series A totalling mid-7-figure € incl existing investor bm-t 2023-06-13
Chinook Therapeutics–Novartis: investment, 202306– acquisition $3.2b cash upfront + $300m cash milestones of Chinook by Novartis ANNOUNCED 2023-06-12
Upstream Bio–SEVERAL: investment, 202306 financing round Series B $200m co-led by Enavate Sciences + Venrock Healthcare Capital Partners 2023-06-08
OntoChem–Holtzbrinck: investment, 202306 acquisition 100% of OntoChem by Digital Science 2023-06-07
Bayer–Acuitas Therapeutics: LNP technology, 202306– collab €na using LNP technology to deliver RNA payloads to liver 2023-06-05
ITM–SEVERAL: investment, 202306 financing round €255m led by Temasek 2023-06-05
Sartorius–Waters: biopharma production technology, 202306– collab expansion integration of PATROL UPLC PAS with Resolute BioSMB platform 2023-06-05
4Pharma–BC Platforms: investment, 202306 acquisition €na of 4Pharma by BC Platforms 2023-06-01
Bico–Swiss Life: real estate, 202306– leaseback 15y of property in Berlin by Scienion from BEOS Light Industrial Germany I fund 2023-06-01
Swiss Life–Bico: real estate, 202306 acquisition €21m of new Scienion property in Berlin by BEOS Light Industrial Germany I fund 2023-06-01
Synaffix–Lonza: investment, 202306 acquisition €100m upfront cash + €60m milestones of Synaffix by Lonza 2023-06-01
Theragnostics–Ariceum Therapeutics: investment, 202306 acquisition 100% of Theragnostics Ltd for $2.5m cash upfront plus $41.5m milestones 2023-06-01
Mithra Pharmaceuticals–BioConfidant: public relations, 202305 service existent by Cohesion Bureau 2023-05-29
CARTemis Therapeutics–Germany (govt): grant, 202305– BMBF grant €4.6m to develop CAR T-cell therapy targeting CXCR5 (to MDC+Charité) 2023-05-26
Michor Consulting–QbD Group: investment, 202305 acquisition of Michor Consulting by QbD Group 2023-05-25
Prosion–10xDNA: investment, 202205 existent 7-figure seed investment by 10xDNA 2023-05-23
Smartbax–Boehringer: investment, 202305 seed financing round totalling €1.2m incl existing investor BIVF 2023-05-23
Smartbax–High-Tech Gründerfonds: investment, 202305 seed financing round totalling €1.2m incl new investor HTGF 2023-05-23
Smartbax–SEVERAL: investment, 202305 seed financing round €1.2m from BIVF + HTGF 2023-05-23
Smartbax–Trophic Communications: public relations, 202305 service existent by Trophic 2023-05-23
Oncimmune–Freenome: investment, 202305 acquisition of Oncimmune Ltd by Freenome 2023-05-22
VectivBio–Ironwood: investment, 202305–202306 acquisition $1b net of cash/debt cash tender offer at $17/share 2023-05-21
Traceless Materials–Germany (govt): grant, 202305– BMUV funding €5.1m for construction of demonstration plant 2023-05-19
Boundless Bio–Bayer: investment, 202305 financing round Series C totalling $100m incl new + co-lead investor Leaps by Bayer 2023-05-16
Boundless Bio–Nextech: investment, 202305 financing round Series C totalling $100m incl existing + co-investor Nextech Invest 2023-05-16
Boundless Bio–SEVERAL: investment, 202305 financing round Series C $100m co-led by Leaps by Bayer + RA Capital 2023-05-16
Boundless Bio–Sophia Genetics: molecular diagnostics, 202305 existent collab develpm ecDNA Harboring Oncogenes clinical trial assay ECHO for BBI-355 2023-05-16
Dualyx–High-Tech Gründerfonds: investment, 202305 financing round Series A totalling €40m incl existing + co-investor HTGF 2023-05-15
Dualyx–SEVERAL: investment, 202305 financing round Series A €40m co-led by Fountain Heathcare Partners + Forbion + Andera Partners 2023-05-15
Exazyme–AIX Ventures: investment, 202305 seed financing round totalling €2m from AIX Ventures + Atlantic Labs 2023-05-15
Exazyme–Altantic Labs: investment, 202305 seed financing round totalling €2m from AIX Ventures + Atlantic Labs 2023-05-15
Exazyme–SEVERAL: investment, 202305 seed financing round €2m from AIX Ventures + Atlantic Labs 2023-05-15
next pagenext page 1 2 3 ... 42 43 44  next pagenext page



Advertisement

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x300px

» top